Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AVARA Rx vs Good Girl Rx

AVARA Rx
Graded #263

Higher grade

vs+0.6999999999999957
Good Girl Rx
Graded #277

Lower grade

The verdict

AVARA Rx takes it — 62.8/100 to 62.1/100, but only just.

AVARA Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. AVARA Rx is a nationwide DTC telehealth platform offering compounded semaglutide and tirzepatide plus brand-name Wegovy, Zepbound, and Foundayo consultations, alongside HRT, TRT, and longevity add-ons. Good Girl Rx is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAVARA Rx +15
43
28
Dose & formulationGood Girl Rx +11
77
88
Clinical oversightGood Girl Rx +5
76
81
Labs & monitoringEven
52
52
FulfillmentGood Girl Rx +8
77
85
Contract termsAVARA Rx +14
55
41
AVARA Rx · left barGood Girl Rx · right bar

The numbers

MetricAVARA RxGood Girl Rx
WeighScore62.8/10062.1/100
GradeCC
Scorecard rank#263#277
Semaglutide$229/mo (starting dose, compounded)$79/mo (microdose tier, 12-month plan, compounded)
Tirzepatide$279/mo (starting dose, compounded)$139/mo (microdose tier, 12-month plan, compounded)
CoverageAll 50 statesAll 50 states
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
AVARA Rx

Graded #263 · C

Strengths

  • Names its pharmacy partner (DiRx Health, Ft Lauderdale FL) — buyers can independently verify its licensure
  • Names its clinical network (Beluga Health) — you can research the platform handling your prescriptions
  • All 50 states explicitly listed on the FAQ — uncommon vs peers that just say 'nationwide'
  • Patient-friendly refunds — full refund if a provider disqualifies you, partial if a weaker dose is prescribed
  • LegitScript verification badge displayed; pharmacy claims NABP-accredited facilities

Where it loses points

  • Operating legal entity not disclosed — only a Sheridan, WY registered-agent-style address surfaced
  • Dose pricing not itemized — only 'starting at $229' semaglutide and 'starting at $279' tirzepatide
  • LegitScript certification number not shown — badge only, so no direct lookup
  • No named medical director (Beluga Health is the network, not a named MD)
  • Lab work requirements not specified, and consultation fee not broken out from medication cost
Good Girl Rx

Graded #277 · C

Strengths

  • LegitScript certified
  • Multiple formats — injectable, microdose, and ODT pills — for both semaglutide and tirzepatide
  • Dispensed by licensed 503A or 503B pharmacies
  • Limited brand-name options available (Ozempic, Wegovy, Zepbound, Mounjaro)
  • Named legal entity with a Nashville address

Where it loses points

  • The advertised rates require twelve months paid up front; billed month to month the same products are $184 and $244, roughly 2.3 times as much
  • Every plan is prepaid — the discount exists only on the 3-, 6- and 12-month terms
  • The priced products are microdoses, not labelled therapeutic doses; the standard compounded semaglutide is $134/mo and also needs a year up front
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard